Concepedia
Statistics
Publications
26
Citations
3.5K
H-Index
16
Active since
2001
Affiliations
University of Alabama at Birmingham(Current)
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
The University of Texas MD Anderson Cancer Center
Tina Albertson is an author at University of Alabama at Birmingham specializing in medicine, cell biology, and oncology.
Top concepts
MedicineOncologyCell BiologyImmunotherapyImmunologyCancer ResearchPathologyClinical TrialsImmune SurveillanceHealth
Publications per year
2001–2021
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon et al. · The Lancet · 2020 · 2.2K citations
Hematological Malignancy, Lymphoid Neoplasia, Oncology +5
<i>EARLY FLOWERING3</i> Encodes a Novel Protein That Regulates Circadian Clock Function and Flowering in Arabidopsis
Karen A. Hicks, Tina Albertson, Doris Wagner · The Plant Cell · 2001 · 311 citations
DNA polymerase ε and δ proofreading suppress discrete mutator and cancer phenotypes in mice
Tina Albertson, Masanori Ogawa, James M. Bugni et al. · Proceedings of the National Academy of Sciences · 2009 · 236 citations · Full text
Dna Polymerase ε, Cancer Phenotypes, Genetics +16
Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL.
Jeremy S. Abramson, Leo I. Gordon, Maria Lia Palomba et al. · Journal of Clinical Oncology · 2018 · 166 citations
Drug Safety, Pivotal Trial, Engineering +14
Pivotal Safety and Efficacy Results from Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed/Refractory (R/R) Large B Cell Lymphomas
Jeremy S. Abramson, Maria Lia Palomba, Leo I. Gordon et al. · Blood · 2019 · 114 citations
1–5 of 26